OncoCyte (OCX)
(Delayed Data from NSDQ)
$2.44 USD
-0.02 (-0.81%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $2.40 -0.04 (-1.64%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/9/24 |
---|---|
Current Quarter | -0.82 |
EPS Last Quarter | NA |
Last EPS Surprise | NA |
ABR | 2.40 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.92 |
Next Year | NA |
EPS (TTM) | NA |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.50M | 0.70M | 2.90M | NA |
# of Estimates | 1 | 1 | 1 | NA |
High Estimate | 0.50M | 0.70M | 2.90M | NA |
Low Estimate | 0.50M | 0.70M | 2.90M | NA |
Year ago Sales | 0.30M | 0.46M | 1.50M | 2.90M |
Year over Year Growth Est. | 66.67% | 52.17% | 92.95% | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.82 | -0.53 | -2.92 | NA |
# of Estimates | 1 | 1 | 2 | NA |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.82 | -0.53 | -2.58 | NA |
Low Estimate | -0.82 | -0.53 | -3.25 | NA |
Year ago EPS | -0.80 | -1.07 | -4.37 | -2.92 |
Year over Year Growth Est. | -2.50% | 50.47% | 33.18% | NA |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | NA |
Up Last 30 Days | 0 | 0 | 0 | NA |
Up Last 60 Days | 0 | 0 | 0 | NA |
Down Last 7 Days | 0 | 0 | 0 | NA |
Down Last 30 Days | 0 | 0 | 0 | NA |
Down Last 60 Days | 0 | 0 | 0 | NA |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.82 | -0.53 | -2.92 | NA |
7 Days Ago | -0.82 | -0.53 | -2.92 | NA |
30 Days Ago | -0.82 | -0.53 | -2.92 | NA |
60 Days Ago | -0.82 | -0.53 | -2.92 | NA |
90 Days Ago | -0.82 | -0.53 | -2.92 | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.82 | -0.53 | -2.92 | NA |
Zacks Consensus Estimate | -0.82 | -0.53 | -2.92 | NA |
Earnings ESP | 0.00% | 0.00% | 0.00% | NA |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | NA | -0.57 | -1.07 | -0.80 | NA |
Estimate | NA | -1.52 | -2.60 | -2.40 | NA |
Difference | NA | 0.95 | 1.53 | 1.60 | 1.36 |
Surprise | NA | 62.50% | 58.85% | 66.67% | 62.67% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more